Individual V gamma 2-J gamma 1.2+ T cells respond to both isopentenyl pyrophosphate and Daudi cell stimulation: generating tumor effectors with low molecular weight phosphoantigens
Human V gamma 2V delta 2 T cells exhibit T cell receptor-dependent, MHC-unrestricted recognition of antigen and play important roles in tumor and pathogen immunity. To characterize antigen recognition by the V gamma 2V delta 2 TCR, we used the combined approach of spectratyping and CDR3 sequence ana...
Gespeichert in:
Veröffentlicht in: | Cancer Immunology, Immunotherapy Immunotherapy, 2007-06, Vol.56 (6), p.819-829 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 829 |
---|---|
container_issue | 6 |
container_start_page | 819 |
container_title | Cancer Immunology, Immunotherapy |
container_volume | 56 |
creator | Hebbeler, A M Cairo, C Cummings, J S Pauza, C D |
description | Human V gamma 2V delta 2 T cells exhibit T cell receptor-dependent, MHC-unrestricted recognition of antigen and play important roles in tumor and pathogen immunity. To characterize antigen recognition by the V gamma 2V delta 2 TCR, we used the combined approach of spectratyping and CDR3 sequence analysis that measures changes in the TCR repertoire before and after stimulation with a phosphoantigen (isopentenyl pyrophosphate) or an irradiated tumor cell line (Daudi B lymphoma). Here we describe common V gamma 2 chains that are substantially involved in the response to both phosphoantigens and tumor cells. The recognition properties of common V gamma 2 chains explains the observation that V gamma 2V delta 2 T cells expanded by phosphoantigen stimulation specifically recognize and kill some but not all tumor cell lines. Our studies further justify efforts to stimulate tumor immunity by administering low molecular weight phosphoantigens and boosting the frequency and tumor effector functions of circulating V gamma 2V delta 2 T cells. |
doi_str_mv | 10.1007/s00262-006-0235-6 |
format | Article |
fullrecord | <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_miscellaneous_20310924</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>20310924</sourcerecordid><originalsourceid>FETCH-LOGICAL-p116t-c1c1ebee4686005e48ad9054433803b3d62efda17cfb7f2725c990301ef1bc8b3</originalsourceid><addsrcrecordid>eNotj8tOwzAQRS0EEuXxAexmxQa5jO3Eadih8ipCYgNsKyeZpEaJHWKHiv_iAwnQ1ZzFPUcaxs4EzgVidhkQpZYcUXOUKuV6j82E0imXqc722QxVgjxDTA7ZUQjvE0jM8xn7XrnKftpqNC28QWO6zoDkjzsSc3kBL1BS2wYYKPTeVRA9FD5uwAbfk4vkvlrovwbfb3zoNyYSmGl1Y8bK_pkQou3G1kTr3RU05GiY2DUQx84PQHVNZfRDgK2dqq3fQudbKidjgC3ZZhPhP-2Ni3bywwk7qE0b6HR3j9nr3e3L8oE_Pd-vltdPvBdCR16KUlBBlOiFRkwpWZgqxzRJlFqgKlSlJdWVEVlZF1ktM5mWeY4KBdWiKBeFOmbn_91-8B8jhbjubPh9yTjyY1hLVAJzmagfxxt4Ag</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20310924</pqid></control><display><type>article</type><title>Individual V gamma 2-J gamma 1.2+ T cells respond to both isopentenyl pyrophosphate and Daudi cell stimulation: generating tumor effectors with low molecular weight phosphoantigens</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Wiley Free Content</source><source>IngentaConnect Free/Open Access Journals</source><source>Wiley Online Library All Journals</source><source>PubMed Central</source><source>SpringerLink Journals - AutoHoldings</source><creator>Hebbeler, A M ; Cairo, C ; Cummings, J S ; Pauza, C D</creator><creatorcontrib>Hebbeler, A M ; Cairo, C ; Cummings, J S ; Pauza, C D</creatorcontrib><description>Human V gamma 2V delta 2 T cells exhibit T cell receptor-dependent, MHC-unrestricted recognition of antigen and play important roles in tumor and pathogen immunity. To characterize antigen recognition by the V gamma 2V delta 2 TCR, we used the combined approach of spectratyping and CDR3 sequence analysis that measures changes in the TCR repertoire before and after stimulation with a phosphoantigen (isopentenyl pyrophosphate) or an irradiated tumor cell line (Daudi B lymphoma). Here we describe common V gamma 2 chains that are substantially involved in the response to both phosphoantigens and tumor cells. The recognition properties of common V gamma 2 chains explains the observation that V gamma 2V delta 2 T cells expanded by phosphoantigen stimulation specifically recognize and kill some but not all tumor cell lines. Our studies further justify efforts to stimulate tumor immunity by administering low molecular weight phosphoantigens and boosting the frequency and tumor effector functions of circulating V gamma 2V delta 2 T cells.</description><identifier>ISSN: 0340-7004</identifier><identifier>EISSN: 1365-2567</identifier><identifier>DOI: 10.1007/s00262-006-0235-6</identifier><language>eng</language><ispartof>Cancer Immunology, Immunotherapy, 2007-06, Vol.56 (6), p.819-829</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Hebbeler, A M</creatorcontrib><creatorcontrib>Cairo, C</creatorcontrib><creatorcontrib>Cummings, J S</creatorcontrib><creatorcontrib>Pauza, C D</creatorcontrib><title>Individual V gamma 2-J gamma 1.2+ T cells respond to both isopentenyl pyrophosphate and Daudi cell stimulation: generating tumor effectors with low molecular weight phosphoantigens</title><title>Cancer Immunology, Immunotherapy</title><description>Human V gamma 2V delta 2 T cells exhibit T cell receptor-dependent, MHC-unrestricted recognition of antigen and play important roles in tumor and pathogen immunity. To characterize antigen recognition by the V gamma 2V delta 2 TCR, we used the combined approach of spectratyping and CDR3 sequence analysis that measures changes in the TCR repertoire before and after stimulation with a phosphoantigen (isopentenyl pyrophosphate) or an irradiated tumor cell line (Daudi B lymphoma). Here we describe common V gamma 2 chains that are substantially involved in the response to both phosphoantigens and tumor cells. The recognition properties of common V gamma 2 chains explains the observation that V gamma 2V delta 2 T cells expanded by phosphoantigen stimulation specifically recognize and kill some but not all tumor cell lines. Our studies further justify efforts to stimulate tumor immunity by administering low molecular weight phosphoantigens and boosting the frequency and tumor effector functions of circulating V gamma 2V delta 2 T cells.</description><issn>0340-7004</issn><issn>1365-2567</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><recordid>eNotj8tOwzAQRS0EEuXxAexmxQa5jO3Eadih8ipCYgNsKyeZpEaJHWKHiv_iAwnQ1ZzFPUcaxs4EzgVidhkQpZYcUXOUKuV6j82E0imXqc722QxVgjxDTA7ZUQjvE0jM8xn7XrnKftpqNC28QWO6zoDkjzsSc3kBL1BS2wYYKPTeVRA9FD5uwAbfk4vkvlrovwbfb3zoNyYSmGl1Y8bK_pkQou3G1kTr3RU05GiY2DUQx84PQHVNZfRDgK2dqq3fQudbKidjgC3ZZhPhP-2Ni3bywwk7qE0b6HR3j9nr3e3L8oE_Pd-vltdPvBdCR16KUlBBlOiFRkwpWZgqxzRJlFqgKlSlJdWVEVlZF1ktM5mWeY4KBdWiKBeFOmbn_91-8B8jhbjubPh9yTjyY1hLVAJzmagfxxt4Ag</recordid><startdate>20070601</startdate><enddate>20070601</enddate><creator>Hebbeler, A M</creator><creator>Cairo, C</creator><creator>Cummings, J S</creator><creator>Pauza, C D</creator><scope>7T5</scope><scope>H94</scope></search><sort><creationdate>20070601</creationdate><title>Individual V gamma 2-J gamma 1.2+ T cells respond to both isopentenyl pyrophosphate and Daudi cell stimulation: generating tumor effectors with low molecular weight phosphoantigens</title><author>Hebbeler, A M ; Cairo, C ; Cummings, J S ; Pauza, C D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p116t-c1c1ebee4686005e48ad9054433803b3d62efda17cfb7f2725c990301ef1bc8b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hebbeler, A M</creatorcontrib><creatorcontrib>Cairo, C</creatorcontrib><creatorcontrib>Cummings, J S</creatorcontrib><creatorcontrib>Pauza, C D</creatorcontrib><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Cancer Immunology, Immunotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hebbeler, A M</au><au>Cairo, C</au><au>Cummings, J S</au><au>Pauza, C D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Individual V gamma 2-J gamma 1.2+ T cells respond to both isopentenyl pyrophosphate and Daudi cell stimulation: generating tumor effectors with low molecular weight phosphoantigens</atitle><jtitle>Cancer Immunology, Immunotherapy</jtitle><date>2007-06-01</date><risdate>2007</risdate><volume>56</volume><issue>6</issue><spage>819</spage><epage>829</epage><pages>819-829</pages><issn>0340-7004</issn><eissn>1365-2567</eissn><abstract>Human V gamma 2V delta 2 T cells exhibit T cell receptor-dependent, MHC-unrestricted recognition of antigen and play important roles in tumor and pathogen immunity. To characterize antigen recognition by the V gamma 2V delta 2 TCR, we used the combined approach of spectratyping and CDR3 sequence analysis that measures changes in the TCR repertoire before and after stimulation with a phosphoantigen (isopentenyl pyrophosphate) or an irradiated tumor cell line (Daudi B lymphoma). Here we describe common V gamma 2 chains that are substantially involved in the response to both phosphoantigens and tumor cells. The recognition properties of common V gamma 2 chains explains the observation that V gamma 2V delta 2 T cells expanded by phosphoantigen stimulation specifically recognize and kill some but not all tumor cell lines. Our studies further justify efforts to stimulate tumor immunity by administering low molecular weight phosphoantigens and boosting the frequency and tumor effector functions of circulating V gamma 2V delta 2 T cells.</abstract><doi>10.1007/s00262-006-0235-6</doi><tpages>11</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0340-7004 |
ispartof | Cancer Immunology, Immunotherapy, 2007-06, Vol.56 (6), p.819-829 |
issn | 0340-7004 1365-2567 |
language | eng |
recordid | cdi_proquest_miscellaneous_20310924 |
source | Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Wiley Free Content; IngentaConnect Free/Open Access Journals; Wiley Online Library All Journals; PubMed Central; SpringerLink Journals - AutoHoldings |
title | Individual V gamma 2-J gamma 1.2+ T cells respond to both isopentenyl pyrophosphate and Daudi cell stimulation: generating tumor effectors with low molecular weight phosphoantigens |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T16%3A57%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Individual%20V%20gamma%202-J%20gamma%201.2+%20T%20cells%20respond%20to%20both%20isopentenyl%20pyrophosphate%20and%20Daudi%20cell%20stimulation:%20generating%20tumor%20effectors%20with%20low%20molecular%20weight%20phosphoantigens&rft.jtitle=Cancer%20Immunology,%20Immunotherapy&rft.au=Hebbeler,%20A%20M&rft.date=2007-06-01&rft.volume=56&rft.issue=6&rft.spage=819&rft.epage=829&rft.pages=819-829&rft.issn=0340-7004&rft.eissn=1365-2567&rft_id=info:doi/10.1007/s00262-006-0235-6&rft_dat=%3Cproquest%3E20310924%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=20310924&rft_id=info:pmid/&rfr_iscdi=true |